---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-163395"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:50:48.884385+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Lyra stockholders approve officer exculpation amendment and elect two Class I directors

## Summary
- Officer exculpation amendment approved: 38.8M for, 1.2M against, 8k abstain.
- Class I directors elected: Poukalov (38.6M for) and Snyderman (33.4M for).
- BDO USA ratified as auditor for FY2024: 47.5M for, 47.7k against.

## SEC filing metadata
- accession: 0001193125-24-163395
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312524163395/0001193125-24-163395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312524163395/d614069d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-163395
- JSON: https://secwatch.observer/filing/0001193125-24-163395.json
- Plain text: https://secwatch.observer/filing/0001193125-24-163395.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.